Global Disease Population Statistics · Teeth & oral health · 2026-10-18
Lip and oral cavity cancer
Click a country on the map or in the ranking to see its prevalence, estimated number of people, and how many know they have it, are treated and are controlled.
Global lip and oral cavity cancer
new cases in 2022 · 2022 · estimate
0
- Deaths in 2022188,438
- Rank (lip, mouth, oropharynx combined)#13
- Share of new cases in Asia≈70%
WHO oral health fact sheet (Mar 2025) citing IARC GLOBOCAN 2022: 389,846 new cases and 188,438 deaths from lip and oral cavity cancer in 2022, more common in men and older people; tobacco, alcohol and areca nut (betel quid) are the leading causes. The IARC 2024 estimates (released 2026) give 452,205 cases / 194,108 deaths, about 70% of new cases in Asia. Country figures (map) are IARC 2020 incidence rates as published in WHO GHO oral health profiles. Taiwan: oral cancer (incl. oropharynx and hypopharynx) ranked 6th among new cancers in 2023 (4th in men), median age at diagnosis 60 (MOHW Cancer Registry 2023).
Sources: WHO Fact sheet: Oral health (2025-03-17) · IARC GLOBOCAN 2024: Lip, oral cavity fact sheet
Loading map…
Care gap
Pick a country
—
WHO GHO does not publish screening/treatment coverage for oral cancer.
Definition and age band
Crude incidence of lip and oral cavity cancer (ICD-10 C00–C06) per 100,000 population, both sexes, IARC GLOBOCAN 2020 estimates as published in WHO GHO oral health profiles; counts are new cases per year. Taiwan (not in GHO) is described from the MOHW Cancer Registry and not placed on the same scale.
Sources
Country figures come from the WHO Global Health Observatory (GHO) public API and are modelled estimates (NCD-RisC, WHO hepatitis programme) with differing years; Taiwan is outside the WHO system and is entered manually from HPA/CDC publications, flagged as such. GHO data fetched: 2026-10-18. WHO GHO · ORAL_HEALTH_CANCER_LIPORALCAVITY_100K
This page summarises epidemiological statistics and is not individual medical advice; discuss your personal risk with your care team. The content of this article is personal reflection and experience sharing only, and is not medical advice. For any questions about your health, illness or physical care, please seek help through professional medical channels and consult your physician.
| Country/territory | Incidence per 100,000 |
|---|---|
| India | 9.8 /100k |
| Australia | 6.5 /100k |
| France | 5.4 /100k |
| United Kingdom | 5.1 /100k |
| Russia | 5.1 /100k |
| Spain | 4.5 /100k |
| Germany | 4.3 /100k |
| United States | 4.2 /100k |
| Canada | 4.2 /100k |
| Thailand | 4 /100k |
| South Africa | 3.8 /100k |
| Brazil | 3.6 /100k |
| Japan | 3.4 /100k |
| Italy | 2.8 /100k |
| Singapore | 2.3 /100k |
| Malaysia | 2.2 /100k |
| Turkey | 2.1 /100k |
| South Korea | 2 /100k |
| Indonesia | 2 /100k |
| Philippines | 1.7 /100k |
| Saudi Arabia | 1.7 /100k |
| Egypt | 1.6 /100k |
| Mainland China | 1.3 /100k |
| Nigeria | 1.2 /100k |
| Mexico | 1.1 /100k |
| Taiwan ※ | — |
※ Different definition/age band — not directly comparable with other countries on the map
